PubMed=1980607; DOI=10.1002/gcc.2870020112
Bruderlein S., van der Bosch K., Schlag P.M., Schwab M.
Cytogenetics and DNA amplification in colorectal cancers.
Genes Chromosomes Cancer 2:63-70(1990)

PubMed=7812507; DOI=10.1007/BF00196144
Koretz K., Bruderlein S., Henne C., Fietz T., Laque M., Moller P.
Comparative evaluation of integrin alpha- and beta-chain expression in colorectal carcinoma cell lines and in their tumours of origin.
Virchows Arch. 425:229-236(1994)

PubMed=8168998; DOI=10.1002/ijc.2910570314
Moller P., Koretz K., Leithauser F., Bruderlein S., Henne C., Quentmeier A., Krammer P.H.
Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium.
Int. J. Cancer 57:371-377(1994)

PubMed=24755471; DOI=10.1158/0008-5472.CAN-14-0013
Mouradov D., Sloggett C., Jorissen R.N., Love C.G., Li S., Burgess A.W., Arango D., Strausberg R.L., Buchanan D., Wormald S., O'Connor L., Wilding J.L., Bicknell D.C., Tomlinson I.P.M., Bodmer W.F., Mariadason J.M., Sieber O.M.
Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.
Cancer Res. 74:3238-3247(2014)